Sign In
Buy LLY
$1,185.71
-6.23 (-0.523%)
At Close: Aug 07, 2026
Which Is the Better Passive Income Stock, Eli Lilly or Bristol Myers Squibb?
10:15am, Friday, 05'th May 2023
There are often trade-offs to make when selecting passive income stocks. Eli Lilly's next couple of years will see its revenue burgeon by billions.
This Top Fund Manager Buys Growth Stocks Without Paying Too Much
07:00am, Friday, 05'th May 2023
Daniel Morris, manager of top mutual fund Manor Growth Fund (MNRGX), admits he has a conservative streak. The post This Top Fund Manager Buys Growth Stocks Without Paying Too Much appeared first on In
Which Healthcare Stock Is a Compelling Pick for the Long Haul?
03:29pm, Thursday, 04'th May 2023
Investors remain puzzled due to persistent macro challenges, continued interest rate hikes, and the regional banking crisis. Given the ongoing uncertainties, sectors that are resilient during economic
Eli Lilly's Alzheimer's Breakthrough: A Game Changer For Investors And Patients
10:55am, Thursday, 04'th May 2023
Eli Lilly's donanemab shows promise in slowing Alzheimer's progression, offering significant market potential. Competitive landscape between Eli Lilly, Eisai, and Biogen could drive further innovation
Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know
10:41am, Thursday, 04'th May 2023
Zacks.com users have recently been watching Lilly (LLY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Should Investors Buy This Hot Growth Stock?
10:15am, Thursday, 04'th May 2023
Eli Lilly's financial results were challenged by a recent decision from the FDA. The stock's dividend payout is modest but positioned to grow robustly.
Here's the Best Reason to Buy Eli Lilly Stock Right Now
09:23am, Thursday, 04'th May 2023
The pharmaceutical giant's first-quarter results were hardly impressive. But the company's drug Mounjaro recently reported an important clinical win.
These Have Been 3 of the Best-Performing Healthcare Stocks Since 2020
05:57am, Thursday, 04'th May 2023
Demand for Moderna's COVID-19 vaccine will taper off this year, but investors remain bullish on its prospects. McKesson is a top distributor of pharmaceuticals and a key cog in the healthcare industry
Should You Buy Eli Lilly Stock Now?
05:13am, Thursday, 04'th May 2023
Eli Lilly announced the successful results of a phase 3 trial with donanemab, an experimental treatment for Alzheimer's disease. Treatment with the Alzheimer's disease candidate appeared to reduce the
Obesity drug could be a 'big upside' for Eli Lilly, says Wells Fargo's Mohit Bansal
07:19pm, Wednesday, 03'rd May 2023
Mohit Bansal, Wells Fargo managing director, joins 'Fast Money' to talk Eli Lilly drug trials, it's competition with Biogen for an alzheimer's drug, and more.
Eli Lilly stock soars following data suggesting its Alzheimer's drug can slow illness
06:02pm, Wednesday, 03'rd May 2023
Shares of Eli Lilly and Company surge after drug trial data suggests the pharmaceutical company's Alzheimer's treatment drug can potentially slow the illness.
Eli Lilly's positive results from a Alzheimer's trial seen as ‘potentially very important'
02:07pm, Wednesday, 03'rd May 2023
Positive results from an Alzheimer's trial by Eli Lilly are seen as a very important step in the battle to fight the fatal disease, but questions remain about whether it will be covered by Medicare.
Why Eli Lilly Stock Is Bolting Higher Today
01:59pm, Wednesday, 03'rd May 2023
Eli Lilly announced better-than-expected trial results for its early-stage Alzheimer's disease candidate, donanemab, today. The drug's latest results paint an encouraging picture for patients.
SNY or LLY: Which Is the Better Value Stock Right Now?
12:55pm, Wednesday, 03'rd May 2023
Investors looking for stocks in the Large Cap Pharmaceuticals sector might want to consider either Sanofi (SNY) or Eli Lilly (LLY). But which of these two companies is the best option for those lookin
Promising data from Eli Lilly shows a significant slowdown in the pace of Alzheimer's
12:20pm, Wednesday, 03'rd May 2023
CNBC's Bertha Coombs joins 'Squawk on the Street' to discuss Eli Lilly receiving an upgrade following news that the company's Alzheimer's treatment drug Donanemab significantly slows disease progressi
